Log In
Print
BCIQ
Print
Print this Print this
 

Aminoacyl tRNA synthetase fragments (Tmax) (ATYR0030)

  Manage Alerts
Collapse Summary General Information
Company aTyr Pharma Inc.
DescriptionRecombinant form of a signaling peptide derived from human aminoacyl tRNA synthetases
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationNeuropathy
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today